Mahadevia Ankit 4
4 · Spero Therapeutics, Inc. · Filed Aug 30, 2023
Insider Transaction Report
Form 4
Mahadevia Ankit
Director
Transactions
- Sale
Common Stock
2023-08-28$1.26/sh−9,040$11,390→ 788,792 total
Footnotes (2)
- [F1]The reported transaction is a sale of common stock effected to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") that were granted to the Reporting Person on August 26, 2021 pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F2]Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.